Home > Diagnoses & Conditions > Asthma > Ongoing Assessment

Asthma - Ongoing Assessment

Overview

The goals for each visit should include classifying both the level of asthma control and the risk for exacerbation in order to guide adjustments in management or therapy. The Asthma action plan, child, English (PDF Document) should be revised depending on the current symptoms of the child. Guidelines for ongoing assessment are summarized below and resources and tools provided.

Screening

No screening is recommended for asthma. For siblings of children with asthma and for children with a strong family history of atopy, consider an asthma evaluation for recurrent or persistent respiratory symptoms, including cough.

Diagnostic Criteria

Three general criteria for the diagnosis of asthma, include:
  1. symptoms of recurrent airway obstruction or airway hyperresponsiveness,
  2. symptoms/signs are at least partially reversible, and
  3. alternative diagnoses have been excluded.
These criteria are determined by a detailed history and physical and spirometry testing. Spirometry, required by criterion 2, cannot be reliably performed in children who are younger than 5 years of age. Younger children should be given a provisional diagnosis of asthma and treated appropriately, but the diagnosis should be frequently reassessed to avoid prolonged, unnecessary treatment in a child who doesn't really have asthma.

History And Examination

Goals include:
  • assessment of asthma control and risk of exacerbations to guide therapeutic decisions, and
  • understanding the impact of asthma on the child and family to guide seeking additional resources and/or accommodations in the school or community.

Interim History

Have there been any exacerbations since the last visit? Any urgent, emergent, or subspecialist visits, or visits to another primary care provider?

Have there been any changes in precipitating and/or aggravating factors, particularly allergen, pollutant, or irritant exposures, such as tobacco smoke or dust mites? For a list of allergens, see Environmental modifications for asthma (2007 NHLBI Guidelines) (PDF Document 69 KB) .

Any changes in comorbid conditions, including gastroesophageal reflux, obesity, obstructive sleep apnea, rhinitis or sinusitis, stress and depression, or Allergic bronchopulmonary aspergillosis (ABPA)?

Do asthma symptoms result in any limitations to physical activity, exertion, play, excercise, sleep, etc.?

Review all medications being used, assessing frequency and technique. Ask specifically about use of complementary and alternative therapies (CAM) and any reasons for not using prescribed medications.

Any medication side effects noted (particularly headache, sleeplessness, nausea, nervousness/tremors, thrush)?

The Patient self-assessment record (2007 NHLBI Guidelines) (PDF Document 54 KB) may be useful. [National: 2007]

Developmental and Educational Progress

How much school has been missed due to asthma-related issues?

How is school performance affected by asthma symptoms or medications? Is the child able to fully participate in sports, PE? See Exercise induced bronchospasm.

Social and Family Functioning

How has asthma affected the child's social interactions and recreation? Problems with family adjustment to asthma?

Physical Exam

Vital Signs

RR | HR | BP (medications may cause elevation), pulsus paradoxus if asthma symptoms present

Growth Parameters

height and weight (current and patterns of gain), for evidence of other chronic underlying disease (e.g., cystic fibrosis), effect of medications, obesity (which might complicate asthma)

Skin

evidence of atopy/eczema

Chest

evidence of accessory muscle use (tracheal tugging, intercostal retractions, nostril flaring, increased abdominal movement), sounds of expiratory wheezing with normal breathing or with forced expiration, prolonged expiratory phase, hyperexpansion of the thorax, hunched shoulders

HEENT

evidence of allergy (periorbital swelling, conjunctival injection or edema, nasal discharge, nasal polyps, pale or swollen nasal turbinates, Denny's lines, mouth breathing), sinusitis, otitis media or effusion

Extremities

cyanosis, clubbing (suggests other diagnoses, particularly cystic fibrosis)

Testing

Other Testing

Spirometry - (See Services) used in children 5 and older to assess airflow obstruction and reversibility with treatment. In children younger than 5, see Asthma in young children (< 5 years). In children with asthma, airflow obstruction should be present and it should be reversible within 15-20 min. after inhalation of a short acting bronchodilator. Airflow obstruction is measured by comparing the forced expiratory volume in 1 second (FEV1) and the FEV1 to Functional Vital Capacity (FVC) ratio to normal values for age. Reversibility is shown by an increase in FEV1 by 12% or a 200 ml increase. For more information see Asthma spirometry basics (getasthmahelp.org) (PDF Document 219 KB) . Spirometry should then be repeated periodically, including after treatment is initiated and symptoms and PEF have stabilized to document attainment of (near) normal airway function, or if asthma is not well controlled, and at a minimum of every 1 to 2 years. Spirometry measures should be followed chronically to detect any decline in pulmonary function over time [National: 2007].

Peak flow measurements - After initial diagnosis, peak flow measurements can be used to monitor response to treatment over time. It is quick, easy, and inexpensive, and with practice can be sufficiently reliable to guide daily therapy or as an in-office assessment tool (see Peak flow sample chart (Asthma and Allergy Information and Research) and Peak flow meter information (American Lung Association)). Although there is less emphasis on peak flow measurements in the most recent guidelines, these measurements are still in widespread use, and can be very helpful in certain patients as long as providers/families understand the pitfalls of peak flow use:
  • They are extremely effort dependent.
  • Personal best should be used as the 100% value, as opposed to predicted values.
  • Many children cannot perform an adequate peak flow maneuver, making the value invalid.
  • Personal best increases with height (as do predicted values).
  • They are not as sensitive in children as FEV1 or FEF 25-75 for assessing airflow obstruction.

Subspecialist Collaborations and Other Resources

Pulmonary Function Testing (see Services below for relevant providers)

Spirometry and additional testing such as challenge testing are available in the laboratory when appropriate. Education regarding symptoms, how to use a peak flow meter and inhaler, etc. is also offered in many PFT laboratories.

Pediatric Pulmonology (see Services below for relevant providers)

A referral to an asthma specialist might be helpful if symptoms are atypical or if additional testing, such as a challenge, are needed for diagnosis. Also consider referral for specialty consultation and/or management when: two or more bursts of oral steroids are needed within 6 months, an exacerbation requires hospitalization, care is at the step 4 level or higher (see Treatment & Management), immuno-therapy is being considered, or additional testing is needed.

Pediatric Allergy (see Services below for relevant providers)

Consider referral for subcutaneous allergen immunotherapy if there is an obvious relationship between persistent asthma symptoms and sensitivity to a particular allergen, as well as management of asthma.

Comorbid Conditions

Gastroesophageal reflux disease (GERD) is a common comorbid condition and may serve to trigger asthma symptoms. Acid from reflux may causes injury to the lining of the throat, airways and lungs, causing a persistent cough. Children with reflux may have shortness of breath when acid enters the esophagus, triggering airway narrowing to prevent the acid from entering. GERD should be suspected when the child with asthma isn't responding well to asthma medications. If suspected, the provider might consider a trial of a proton pump inhibitor such as lansoprazole or an H2 blocker.

Sinusitis
is another common comorbid condition with asthma. Sinusitis signs and symptoms (nasal obstruction, purulent discharge, localized sinus pain, drainage, and fever) should be asked about/looked for in the asthma history and exam and sinusitis should be treated if present. Consider sinusitis if the child's asthma is not responding well to medication.

Resources

Tools

After assessing the child, the asthma action plan should be revised based on current symptoms.

Asthma action plan, Spanish (PDF Document)
This child asthma action plan in Spanish is from the EPR Guidelines, 2007, and is adapted by them from the California asthma resources.

Asthma action plan, child, English (PDF Document)
This asthma action plan is from the Asthma EPR Guidelines, 2007, and is adapted from California's asthma resources.

Environmental modifications for asthma (2007 NHLBI Guidelines) (PDF Document 69 KB)
Information from the 2007 NHLBI Guidelines for Asthma Diagnosis and Management regarding the control of environmental triggers for asthma.

Patient self-assessment record (2007 NHLBI Guidelines) (PDF Document 54 KB)
A sample record for patients to track asthma symptoms and medication use from the 2007 NHLBI Guidelines.

Peak flow sample chart (Asthma and Allergy Information and Research)
A downloadable peak flow chart for patient use.

Services

Pediatric Allergy

See all Pediatric Allergy services providers (7) in our database.

Pediatric Pulmonology

Pediatric Asthma Program, more info...
100 N Mario Capecchi Dr
Salt Lake City, UT 84103
Phone: 801-662-1765
http://intermountainhealthcare.org/xp/public/primary/docsclinics/clinics/asthma.xml

See all Pediatric Pulmonology services providers (5) in our database.

Pulmonary Function Testing

See all Pulmonary Function Testing services providers (38) in our database.

For other services related to this condition, browse our Services categories or search our database.

Authors

Lead Author: Lynne M Kerr MD, PhD, 2/2008
Reviewing Author: Derek Uchida MD, 3/2008
Content Last Updated: 3/2008

Page Bibliography

National Asthma Education and Prevention Program Expert Panel.
Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma - Summary Report 2007.
National Institutes of Health: National Heart, Lung, and Blood Institute; (2007) http://www.nhlbi.nih.gov/guidelines/asthma/asthsumm.htm. Accessed on 3/31/08.